Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Nammi Therapeutics Inc
Pfizer
Eli Lilly and Company
ViroMissile, Inc.
Angiex, Inc.
Poseida Therapeutics, Inc.
MacroGenics
City of Hope Medical Center
Cue Biopharma
City of Hope Medical Center
Degron Therapeutics Co.
Nuvation Bio Inc.
Actym Therapeutics, Inc.
Exelixis
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Trishula Therapeutics, Inc.
Novita Pharmaceuticals, Inc.
Trishula Therapeutics, Inc.
NextPoint Therapeutics, Inc.
Celldex Therapeutics
Jiangsu Hansoh Pharmaceutical Co., Ltd.
DEKA Biosciences
Pfizer
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Orion Biotechnology Polska Sp. z o.o.
LaunXP Biomedical Co., Ltd.
Molecure S.A.
National Cancer Institute (NCI)
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Astellas Pharma Inc
Eli Lilly and Company
Shanghai PerHum Therapeutics Co., Ltd.
NGM Biopharmaceuticals, Inc
Danatlas Pharmaceuticals Co., Ltd
Pfizer
Xencor, Inc.
Pfizer
ADC Therapeutics S.A.
Shanghai YingLi Pharmaceutical Co. Ltd.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
OHSU Knight Cancer Institute